a leading supplier of diagnostic innovation

Launch Diagnostics is a leading supplier of diagnostic reagents and equipment to the health services of the United Kingdom, Republic of Ireland and France

Introduction of ACCUSAY Diagnostics
ACCUSAY Diagnostics logo


Launch Diagnostics Limited is pleased to announce the formation of ACCUSAY Diagnostics to provide dedicated sales, marketing and technical service to our customers in the Republic of Ireland.


Introducing New Product Ranges from Launch Diagnostics...

ACCUSAY Calprotectin™ is a quantitative enzyme-linked immunoassay for the detection of calprotectin in stool or plasma samples. Stool samples giving values above 50 µg/g are regarded as having a positive ACCUSAY Calprotectin™ result.
DiaSorin Logo

With over 40 years experience in developing, producing and marketing reagent kits, DiaSorin is a market leader in the field of infectious disease diagnostics.  The range includes products for HIV, HCV, Syphilis and the unique Biotrin Parvovirus assay.


Devyser AB is a Swedish company based in Stockholm and was established in 2006. They specialise in DNA analytical procedures including QF-PCR. The main areas of application for their products are prenatal diagnostics, such as rapid aneuploidy detection (RAD) and clinical genetics. They also have the Devyser CFTR Core kit which detects 36 mutations in the CFTR gene responsible for Cystic Fibrosis (CF).

Product News


Fast-Track Diagnostics is continually developing and expanding their range of real time PCR for the detection of viruses, bacteria, parasites and fungi. New for 2014 is the Flu Differentiation panel to make a total of 16 different assays for the detection of respiratory infections.

Fujirebio Europe Logo

Innogenetics N.V. officially becomes Fujirebio Europe N.V. as from 1st October 2013.

illumigene mycoplasma

Meridian Bioscience Inc., has launched the new FDA approved and CE marked illumigene® Mycoplasma DNA amplification assay, a qualitative in vitro diagnostic test for the direct detection of DNA from Mycoplasma pneumoniae in human throat and nasopharyngeal swabs obtained from patients suspected of having Mycoplasma pneumoniae infection.


Product Groups


» Bacteriology

» Biochemistry

» Genetics


» Haematology

» Histology

» Immunology


» Instrumentation

» Neurodegeneration

» Parasitology/Mycology


» Publications

» Transplantation

» Virology